


Ask a doctor about a prescription for CODINEX 1 mg/mL + 1 mg/mL + 6.67 mg/mL SYRUP
Package Leaflet: Information for the Patient
Codinex 1 mg/ml + 1 mg/ml + 6.67 mg/ml Syrup
Codeine Phosphate Hemihydrate / Ephedrine Hydrochloride / Potassium Sulfoguaiacolate
Read the package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Codinex is an association of codeine phosphate, an antitussive for the relief of cough, ephedrine hydrochloride, which relieves nasal congestion, and potassium sulfoguaiacolate, which facilitates the elimination of respiratory secretions.
Codinex is indicated in adults for the symptomatic treatment of respiratory conditions accompanied by cough, especially dry cough (not accompanied by mucus), and nasal congestion.
Do not take Codinex:
Warnings and Precautions
Consult your doctor or pharmacist before starting to take Codinex.
Codinex should be used with caution in the following conditions:
It is not recommended to take this medication for more than three days.
Prolonged and excessive administration of this medication can cause dependence and/or tolerance.
Codeine is converted to morphine in the liver by an enzyme. Some people have a variant of this enzyme that can affect them differently. In some people (a small part of the population), morphine is not produced or is produced in very low amounts, and it will not have an effect on their cough symptoms. In other people (a small proportion of the European population), a very high amount of morphine can be produced, and they are therefore more prone to adverse reactions. If you experience any of the following effects, you should stop taking this medication and seek medical help immediately: slow or shallow breathing, confusion, drowsiness, constricted pupils, nausea, vomiting, constipation, or loss of appetite.
Children and Adolescents
Children under 12 years of age should not take this medication, as they are at a higher risk of experiencing adverse reactions after taking codeine. These reactions can be very serious in children who break down codeine quickly or in large amounts (extensive or ultra-rapid metabolizers). See the "Other adverse effects in children and adolescents" section.
The use of this medication is not recommended in adolescents (12 to 18 years old), especially if they have respiratory problems. See the "Other adverse effects in children and adolescents" section.
Taking Codinex with Other Medications
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
This information is especially important with the following medications, as it may be necessary to modify the dose of one of them or interrupt treatment:
Additionally, the simultaneous use of MAOIs with this medication can potentiate the adverse effects of ephedrine and codeine, as well as those of these medications.
Taking Codinex with Alcohol
Do not drink alcoholic beverages while taking this medication, as it can cause hypotension and severe respiratory depression, as well as symptoms of overdose.
Pregnancy and Breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
Do not take Codinex during pregnancy. Its use can cause physical dependence and changes in the fetus's heartbeat. In the newborn, it can produce withdrawal syndrome and respiratory depression.
Breastfeeding
Do not take this medication if you are breastfeeding. Some components of this medication and their metabolites pass into breast milk and can be harmful to the infant.
Driving and Using Machines
Codinex can cause drowsiness, altering mental and/or physical ability. Avoid driving vehicles or using machines if you notice these effects.
Athletes
This medication contains components that can induce positive results in doping tests.
Codinex Contains Sodium Benzoate (E-211)
This medication contains 2 mg of sodium benzoate per ml of syrup.
Sodium benzoate can increase the risk of jaundice (yellowing of the skin and eyes) in newborns (up to 4 weeks old).
Codinex Contains Ethanol
This medication contains 0.17% mg of ethanol (alcohol), which corresponds to 25.5 mg per 15 ml.
Codinex Contains Sucrose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Patients with diabetes mellitus should note that this medication contains 11.5 g of sucrose per 15 ml.
Codinex Contains Red Colorant Ponceau 4R (E-124)
This medication can cause allergic reactions because it contains the red colorant Ponceau 4R (E-124). It can cause asthma, especially in patients allergic to acetylsalicylic acid.
Codinex Contains Sodium
This medication contains less than 23 mg of sodium (1 mmol) per ml; it is essentially "sodium-free".
Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist again.
The lowest effective dose should be used. The treatment will be as short as possible.
If you do not experience relief from symptoms after three days, you should consult your doctor. See the "Warnings and Precautions" section.
The recommended dose is usually:
Adults: 15 ml every 6 hours or more (maximum of 4 doses per day).
Elderly patients:
Your doctor may recommend lower doses or longer dosing intervals than for younger patients. See the "Warnings and Precautions" section.
Patients with renal and/or hepatic insufficiency:
Your doctor may recommend lower doses than usual. See the "Warnings and Precautions" section.
Use in Children and Adolescents
See the "Children and Adolescents" section in section 2.
If You Take More Codinex Than You Should
Taking very high doses of this medication or taking it with sedatives or alcoholic beverages can cause drowsiness and slow breathing, which can be severe.
It can also cause nausea and vomiting, changes in blood pressure and heart rate, fever, restlessness, and convulsions. Alterations in perception, such as delirium or hallucinations, can occur.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If You Forget to Take Codinex
Do not take a double dose to make up for forgotten doses.
If You Stop Taking Codinex
In case of prolonged use of this medication (see the "Warnings and Precautions" section), administration should be gradually suspended.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
The following side effects have been observed, whose frequency has not been established with precision (frequency not known)
Adverse Reactions Due to Codeine
*Prolonged regular use of this medication can produce tolerance, and treatment interruption should be gradual to avoid withdrawal syndrome. (See the "Warnings and Precautions" section). Restlessness and irritability may appear when treatment is stopped.
Adverse Reactions Due to Ephedrine
Adverse Reactions Due to Potassium Sulfoguaiacolate
Other Adverse Effects in Children and Adolescents
Children under 12 years of age are at a higher risk of experiencing adverse reactions after taking this medication; these reactions can be very serious in children who break down codeine quickly.
In children, taking this medication can have a stimulating effect with nighttime urinary incontinence and cause insomnia, although it can also have a sedative effect in some children.
The symptoms of codeine toxicity could be more severe in adolescents (12 to 18 years old) with respiratory problems, so its use is not recommended in this population.
Reporting Side Effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and any unused medications at the SIGRE collection point in the pharmacy. If you have any doubts, ask your pharmacist how to dispose of the packaging and any unused medications. This will help protect the environment.
Composition ofCodinex
Appearance of the Product and Container Content
Codinex is a transparent, brown-orange syrup with a characteristic aroma.
The medication is presented in:
Each container is provided with a dosing spoon.
Marketing Authorization Holder and Manufacturer
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta.
31620 Huarte (Navarra) - Spain
Date of the last revision of this prospectus: September2020
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for CODINEX 1 mg/mL + 1 mg/mL + 6.67 mg/mL SYRUP – subject to medical assessment and local rules.